Journal
JOURNAL OF CLINICAL NEUROSCIENCE
Volume 30, Issue -, Pages 163-164Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jocn.2016.02.009
Keywords
Aspergillus; Central nervous system; lmmunocompromised; Infliximab; Pneumonia
Categories
Ask authors/readers for more resources
Aspergillus species are emerging as a significant cause of pneumonia mortality in immune compromised hosts, with haematological spread being a rare and life-threatening complication. The central nervous system (CNS) as a site for extrapulmonary spread is rarer still. We report a case of CNS disseminated aspergillosis in a patient treated with corticosteroids and infliximab, an immunomodulatory agent commonly used in the treatment of inflammatory bowel disease, and review the available literature regarding this rare pathology. Crown Copyright (C) 2016 Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available